tiprankstipranks
Trending News
More News >
Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ:PCSA
US Market

Processa Pharmaceuticals (PCSA) Income Statement

Compare
330 Followers

Processa Pharmaceuticals Income Statement

Last quarter (Q4 2025), Processa Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Processa Pharmaceuticals's net income was $-3.36M. See Processa Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.20K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 13.99M$ 12.05M$ 11.46M$ 27.53M$ 12.13M
Depreciation and Amortization
$ 1.20K$ 782.00$ 222.00$ 788.50K$ 790.97K
EBITDA
$ -13.99M$ -12.05M$ -11.46M$ -19.47M$ -10.78M
Operating Income
$ -13.99M$ -12.05M$ -11.46M$ -27.53M$ -12.13M
Other Income/Expenses
$ 424.67K$ 201.09K$ 335.54K$ 101.20K$ 175.40K
Pretax Income
$ -13.56M$ -11.85M$ -11.12M$ -27.42M$ -11.96M
Net Income
$ -13.56M$ -11.85M$ -11.12M$ -27.42M$ -11.43M
Per Share Metrics
Basic EPS
$ -10.36$ -96.75$ -212.00$ -42.50$ -373.00
Diluted EPS
$ -10.36$ -96.75$ -212.00$ -42.50$ -373.00
Weighted Average Shares Outstanding
1.31M 122.40K 52.46K 32.22K 30.64K
Weighted Average Shares Outstanding (Diluted)
1.31M 122.40K 52.46K 32.22K 30.64K
Currency in USD

Processa Pharmaceuticals Earnings and Revenue History